When It Heads South …

… Bad News, Comes Out

Is that where we are with Biotech?

Houston Methodist Sued, $25-million

In what may be just the beginning of similar actions, is this the pivot point?

Part of a lawsuit’s process is ‘discovery’. That’s probably the last thing any ‘institution’ wants.

ZeroHedge picked up the news, linked here; the comment section is telling.

Potential for a significant reversal in SPBIO, has been on the radar for about three-weeks.

What’s price action saying at this juncture?

SPBIO, Daily

For starters, within the first hour of today’s session, we’ve already had an ‘outside-down’ print; last session’s highs and lows have been exceeded by today’s action.

Shifting gears for the next chart, we’re looking at 3X Leveraged Inverse Fund LABD.

LABD, Hourly

The Wyckoff spring set-up is clear. The testing discussed in this update, is per-the-book for Wyckoff action.

‘Tests’ can always fail.

That’s why it’s called ‘The Danger Point’. It’s the location where the risk of being wrong is least (not advice, not a recommendation).

The next chart, also LABD, highlights the record volume on two time-frames, daily and hourly.

This is a potential ‘changing of hands’ from weak to strong for the short-side on SPBIO.

It should be noted, last week’s volume for LABD, was also a record, making it three time-frames.


As this post was being created, LABD continues to rachet lower into what is now a deep test.

Currently trading at LABD 25.98 (mid-session), we’ll see if the test holds and LABD finishes higher for the day.

Meanwhile, the fundamental backdrop and pressure continues to build.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

%d bloggers like this: